MedPath
FDA Approval

EPIPEN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Asclemed USA, Inc.
DUNS: 059888437
Effective Date
August 29, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Epinephrine(0.3 mg in 0.3 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ASCLEMED USA INC. DBA ENOVACHEM

Asclemed USA, Inc.

059888437

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

EPIPEN

Product Details

NDC Product Code
76420-584
Application Number
NDA019430
Marketing Category
NDA (C73594)
Route of Administration
INTRAMUSCULAR
Effective Date
August 29, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: YKH834O4BHClass: ACTIBQuantity: 0.3 mg in 0.3 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACT
© Copyright 2025. All Rights Reserved by MedPath